Get started
Author

Georgina Bowyer

Observed names: Bowyer, Georgina, Bowyer, Georgina SA, Georgina S. Bowyer, Georgina S. Bowyer
Observed institutions: AstraZeneca (United Kingdom), MRC Laboratory of Molecular Biology, University of Cambridge, National Institute for Health and Care Research, University of Oxford, NIHR Oxford Biomedical Research Centre, Jenner Institute, Molecular Immunity Unit
ORCID: 0000-0002-2058-4045
Observed ORCID: 0000-0002-2058-4045
OpenAlex ID: A5088908508
Local and systemic responses to SARS-CoV-2 infection in children and adults
2021 · Masahiro Yoshida, Kaylee B. Worlock, et al. · Nature · 364
PDF
A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA
2015 · Katie Ewer, Tommy Rampling, et al. · New England Journal of Medicine · 348
PDF
Mapping single-cell transcriptomes in the intra-tumoral and associated territories of kidney cancer
2022 · Ruoyan Li, John R. Ferdinand, et al. · Cancer Cell · 244
PDF
Malaria-induced interferon-γ drives the expansion of Tbethi atypical memory B cells
2017 · Nyamekye Obeng-Adjei, Silvia Portugal, et al. · PLoS Pathogens · 163
PDF
Prime-boost vaccination with chimpanzee adenovirus and modified vaccinia Ankara encoding TRAP provides partial protection against Plasmodium falciparum infection in Kenyan adults
2015 · Caroline Ogwang, Domtila Kimani, et al. · Science Translational Medicine · 131
Evaluation of the Efficacy of ChAd63-MVA Vectored Vaccines Expressing Circumsporozoite Protein and ME-TRAP Against Controlled Human Malaria Infection in Malaria-Naive Individuals
2014 · Susanne H. Hodgson, Katie J. Ewer, et al. · The Journal of Infectious Diseases · 128
PDF
Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01BWith Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-TRAP
2016 · Tommy Rampling, Katie J. Ewer, et al. · The Journal of Infectious Diseases · 95
PDF
Activation-induced Markers Detect Vaccine-Specific CD4+ T Cell Responses Not Measured by Assays Conventionally Used in Clinical Trials
2018 · Georgina Bowyer, Tommy Rampling, et al. · Vaccines · 83
PDF
First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children
2018 · Alfred B. Tiono, Issa Nébié, et al. · PLoS ONE · 79
PDF
Safety and Immunogenicity of a Heterologous Prime-Boost Ebola Virus Vaccine Regimen in Healthy Adults in the United Kingdom and Senegal
2018 · Navin Venkatraman, Birahim Pierre Ndiaye, et al. · The Journal of Infectious Diseases · 79
PDF
Prime and target immunization protects against liver-stage malaria in mice
2018 · Anita Gola, Daniel Silman, et al. · Science Translational Medicine · 72
Reduced Ebola vaccine responses in CMV+ young adults is associated with expansion of CD57+KLRG1+ T cells
2020 · Georgina Bowyer, Hannah Sharpe, et al. · The Journal of Experimental Medicine · 54
Translating the Immunogenicity of Prime-boost Immunization With ChAd63 and MVA ME-TRAP From Malaria Naive to Malaria-endemic Populations
2014 · Domtila Kimani, Ya Jankey Jagne, et al. · Molecular Therapy · 54
Safety and efficacy of novel malaria vaccine regimens of RTS,S/AS01B alone, or with concomitant ChAd63-MVA-vectored vaccines expressing ME-TRAP
2018 · Tommy Rampling, Katie J. Ewer, et al. · npj Vaccines · 50
PDF
Viral Vector Malaria Vaccines Induce High-Level T Cell and Antibody Responses in West African Children and Infants
2017 · Carly M. Bliss, Abdoulie Drammeh, et al. · Molecular Therapy · 45
PDF
Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP
2018 · Carly M. Bliss, Georgina Bowyer, et al. · Scientific Reports · 42
PDF
Tissue Immunity in the Bladder
2022 · Georgina S. Bowyer, Kevin W. Loudon, et al. · Annual Review of Immunology · 40
CXCR3+ T Follicular Helper Cells Induced by Co-Administration of RTS,S/AS01B and Viral-Vectored Vaccines Are Associated With Reduced Immunogenicity and Efficacy Against Malaria
2018 · Georgina Bowyer, Amy Grobbelaar, et al. · Frontiers in Immunology · 40
PDF
Safety and immunogenicity of heterologous prime-boost immunization with viral-vectored malaria vaccines adjuvanted with Matrix-M™
2017 · Navin Venkatraman, Nicholas Anagnostou, et al. · Vaccine · 37
A review of Phase I trials of Ebola virus vaccines: what can we learn from the race to develop novel vaccines?
2017 · Teresa Lambe, Georgina Bowyer, et al. · Philosophical Transactions of the Royal Society B Biological Sciences · 33
Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
2019 · Pedro M. Folegatti, Duncan Bellamy, et al. · Vaccines · 30
PDF
Phase I assessments of first-in-human administration of a novel malaria anti-sporozoite vaccine candidate, R21 in matrix-M adjuvant, in UK and Burkinabe volunteers
2019 · Navin Venkatraman, Alfred B. Tiono, et al. · medRxiv · 27
PDF
Safety and Immunogenicity of Malaria Vectored Vaccines Given with Routine Expanded Program on Immunization Vaccines in Gambian Infants and Neonates: A Randomized Controlled Trial
2017 · Victorine A. Mensah, Sophie Roetynck, et al. · Frontiers in Immunology · 27
PDF
Temporal profiling of human lymphoid tissues reveals coordinated defense against viral challenge
2025 · Matthew L. Coates, Nathan Richoz, et al. · Nature Immunology · 23
Obesity Is Associated with Attenuated Tissue Immunity in COVID-19
2022 · Shuang A. Guo, Georgina S. Bowyer, et al. · American Journal of Respiratory and Critical Care Medicine · 22
Works count: 65
Citation count: 2,443
H-index: 23
I10-index: 33
Year
Topic
Type